To Build The Core Competitiveness Of China's Pharmaceutical Companies

Under the modern market economy environment, our country pharmaceutical industry must acquire competitive advantages in order to get survival and development. Not only do the pharmaceutical enterprises need a good manufacturing operation system, also they should have an innovation capacity that makes them take keep-changing market challenges. Especially nowadays, the worldwide financial crisis urges enterprises to focus on studying core competitiveness, which attract a great attention of governments, academy and enterprises. In addition, our country pharmaceutical market is characterized as "duality structure", that is, international pharmaceutical enterprises occupy the higher-end of market with brand medicine and originally developed medicine, however, our country pharmaceutical enterprise that reproduce others' medicine are suffering a high competition in the lower-end of market. Because of a big potential of Chinese pharmaceutical market, it is inevitable for international pharmaceutical enterprises to further expand in the domestic market. Facing more and more internationalized Chinese market, Chinese pharmaceutical enterprise is reaching a key stage of innovation. The main content of this article is studying how to build and improve the core competitiveness of domestic pharmaceutical enterprises and how these enterprises maintain a long-lasting competitive advantage. The enterprise core competitiveness is the drives that can make Chinese pharmaceutical enterprise maintain competitive advantage. Hence, studying this topic can help domestic enterprises find a road to success.This article analyzes various factors that impact and limit the survival and development of domestic pharmaceutical enterprises, and dig inner causes, and combine the actual situation of Chinese pharmaceutical enterprises to find methods and measures for building and improving core competitiveness. First, this article talks about enterprise core competitiveness and relevant theories, and then with these theories analyze various political policies, social and economic environment that Chinese enterprises face. Furthermore, analyze various causes that impact and limit the development of core competitiveness of Chinese enterprises. Finally, propose practical measures and methods for the establishment and improvement of core competitiveness of Chinese enterprises.First, build and improve Chinese pharmaceutical enterprise innovation management theory. The author thinks that for pharmaceutical enterprises, the innovation management is in two: traditional medicine technology innovation and management innovation. This thesis puts an emphasis on the methods for application of international top pharmaceutical management theory into Chinese enterprises.Second, build and improve research type pharmaceutical enterprise. This is a basic measure and guarantee for keeping enterprise core competitiveness. Considering specific nation situation and issues that Chinese pharmaceutical enterprises face in building core competitiveness, the author presents four measures for Chinese enterprises.Third, build and improve medicine R & D technology system. Among many technology innovation modes, the author emphasizes on three R & D modes and according to our country's pharmaceutical enterprise situation, analyzes and suggests our enterprises to use the collaboration development strategy.